Overview

This chapter isolates the upside among German start-ups that survive long enough for BDA to matter. Conditional on survival, adopters had more than 28% higher sales, but the relationship became statistically insignificant when current employees were controlled, so the evidence supports scaling more clearly than higher labour productivity. Sales volatility was also higher: the study reports 42% higher logarithmised normalised variance, 52% higher normalised variance, and €38,202 more fluctuation or 32.5% higher variation relative to mean sales—different expressions of modelled instability. Employee growth was stronger on average and especially pronounced near the upper end of the employee distribution, while the sales upper-tail difference was not statistically settled. These are conditional associations, not guarantees for every adopter or proof of profitability.

Learning outcomes

Among surviving BDA adopters, sales were more than 28% higher, but this does not describe all firms that adopted.
Employee growth is the clearest amplifier signal, with the strongest association near the upper end of the employee distribution.
When current employees were controlled, the sales relationship became statistically insignificant, weakening a productivity interpretation.

Keywords

BDAScalingSalesEmployeesProductivityVolatility

What Surviving Adopters Actually Gain

The German study’s positive results begin only after a difficult filter: the venture must remain in business long enough for its BDA capability to matter. This chapter focuses on what is different among those surviving adopters, and what the evidence does not show. The key distinctions are between a higher sales level and higher productivity, between growth and volatility, and between an average effect and an upper-tail effect. Keeping those distinctions intact is what makes the performance-amplifier claim credible rather than merely optimistic.

Sales rise, but stability and productivity do not follow automatically

The study compares sales over the early life of ventures while accounting for initial size, age, industry, observed founder and firm characteristics, and the interaction between BDA adoption and firm age. The result is a sales premium of more than 28% for start-ups using BDA, conditional on survival. In ordinary language, the surviving adopters tend to sell more than comparable non-adopters in the analysis. The phrase “conditional on survival” is not a footnote. It changes the population to which the positive result applies. It excludes ventures that adopted BDA but did not make it through the observed period.

This is why the sales finding cannot be combined mechanically with the survival finding to produce an average promise for all firms. The earlier result says that adoption is associated with a lower probability of surviving the first seven years. The sales result says that, among ventures that survive, adoption is associated with a higher sales level. Both can be true because they describe different stages and, in part, different sets of firms. A strategy can reduce the number of ventures that reach the later stage while raising the performance of some that do.

The size of the sales premium also needs a careful reading. The researchers examine different points in the sales distribution rather than assuming that the average describes every venture. The coefficient for firms near the 0.9 sales quantile is statistically significant and slightly larger than the average coefficient, while the coefficient near the 0.1 quantile is not statistically significant. But the differences between the quantile effects are not statistically significant, and the interaction between BDA and firm age is not significant. The evidence therefore does not justify the stronger statement that BDA’s sales benefit is proven to be larger for high-performing firms. The upper-end pattern is suggestive, not settled.

The stronger and more consistent sales-related signal is volatility. BDA adopters show a 42% higher logarithmised normalised sales variance, which the study translates into a 52% higher normalised variance. When the researchers first estimate each firm’s expected sales trajectory and then examine fluctuations around that path, adopters have €38,202 more fluctuation, or 32.5% higher variation relative to their mean sales. These are different ways of expressing the modelled instability, not three separate benefits or three independent shocks. The practical meaning is that higher sales can arrive with a less predictable revenue path.

Published by DeepMox

FAQ

What does conditional on survival mean for BDA sales results?

It means the sales comparison applies to ventures that remained in business, not every venture that adopted BDA.

Where was the BDA amplifier effect strongest?

It was strongest in employee growth near the upper end of the distribution: at the 0.9 quantile, adopters had 3.8 more employees and 1.3 more employees in yearly growth than comparable non-adopters.

Why can higher sales coexist with higher volatility?

A higher sales level can accompany a less predictable revenue path; the data cannot distinguish difficult signal interpretation from faster pursuit of opportunities.

Previous11 minGerman Start-ups: BDA and Survival Risk

Next10 minGerman Start-ups: Funding and Integrating BDA

German Start-ups: BDA’s Conditional Growth

What Surviving Adopters Actually Gain

Sales rise, but stability and productivity do not follow automatically

FAQ